Photo: The Economic Times Markets
Business & Finance
Bayer raises 2026 profit outlook on strong pharmaceuticals performance
TL;DR
- Bayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German group also lowered its debt forecast, signalling improving growth momentum and a stronger financial position.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 3, 2026 · Updated 11/3/2026, 8:42:28 AM · Reported with: The Economic Times Markets
Sources (1)
NRI Bytes writes its own articles from the reporting below.
The Economic Times Markets — Bayer raises 2026 profit outlook on strong pharmaceuticals performanceUp next · Business & Finance
Why FS Vikram Misri’s Nepal visit matters ahead of Nepal PM Balen Shah’s proposed India trip? Explained
Read next →
More stories
Business & Finance
India to push for equitable climate finance, practical solutions at COP31
43m ago
Business & Finance
Anthropic warns AI could outpace human control in developing successor models
43m ago
Business & Finance
Russia confirms new Ukraine peace talks as Melania Trump prepares to host ceasefire meeting
43m ago
Business & Finance
India bonds end tad higher on softer oil
43m ago
